TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)

Q: What does CUSIP 881624209 represent in this 13F holders report?

CUSIP 881624209 is the security identifier for TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share used to aggregate holder disclosures.

Q: How many institutions held TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in Q4 2015?

871 institutional investors reported TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share for Q4 2015. Use the holders table for investor-level position and value details.

CUSIP: 881624209

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class: Equity / Ordinary Shares, par value NIS 0.01 per share
Shares outstanding: 1,148,777,709
Total 13F shares: 609,619,633
Share change: +73,883,894
Total reported value: $40,013,406,301
Put/Call ratio: 53%
Price per share: $65.64
Number of holders: 871
Value change: +$4,897,531,260
Number of buys: 382
Number of sells: 371

Quarterly Holders Quick Answers

What is CUSIP 881624209?
CUSIP 881624209 identifies TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2016
Previous quarter: Q3 2015

Recent filing periods for CUSIP 881624209:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	6.3%	72,846,432	$4,112,909,000	—	30 Sep 2015	13F
FRANKLIN RESOURCES INC	13F	Company	4.2%	47,917,298	$2,705,426,000	—	30 Sep 2015	13F
Invesco Ltd.	13F	Company	1.7%	19,300,324	$1,089,697,000	—	30 Sep 2015	13F
PAULSON & CO. INC.	13F	Company	1.6%	18,000,000	$1,016,280,000	—	30 Sep 2015	13F
WADDELL & REED FINANCIAL INC	13F	Company	1.4%	15,846,866	$894,714,000	—	30 Sep 2015	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	1.1%	12,847,566	$725,372,000	—	30 Sep 2015	13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC	13F	Company	0.83%	9,522,401	$537,635,000	—	30 Sep 2015	13F
NORGES BANK	13F	Company	0.82%	9,387,741	$530,032,000	—	30 Sep 2015	13F
VIKING GLOBAL INVESTORS LP	13F	Company	0.77%	8,872,650	$500,950,000	—	30 Sep 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.74%	8,501,944	$480,019,000	—	30 Sep 2015	13F
Allianz Asset Management GmbH	13F	Company	0.74%	8,491,096	$479,407,000	—	30 Sep 2015	13F
HIGHFIELDS CAPITAL MANAGEMENT LP	13F	Company	0.72%	8,292,904	$468,217,000	—	30 Sep 2015	13F
BLACKROCK ADVISORS LLC	13F	Company	0.67%	7,749,470	$437,535,000	—	30 Sep 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.61%	7,056,910	$398,433,000	—	30 Sep 2015	13F
Bank of New York Mellon Corp	13F	Company	0.59%	6,828,451	$385,535,000	—	30 Sep 2015	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.59%	6,736,787	$380,359,000	—	30 Sep 2015	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.48%	5,555,430	$313,660,000	—	30 Sep 2015	13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	13F	Company	0.48%	5,521,241	$311,729,000	—	30 Sep 2015	13F
Mondrian Investment Partners LTD	13F	Company	0.47%	5,384,720	$304,021,000	—	30 Sep 2015	13F
Boston Partners	13F	Company	0.44%	5,003,291	$282,486,000	—	30 Sep 2015	13F
PointState Capital LP	13F	Company	0.43%	4,952,430	$279,614,000	—	30 Sep 2015	13F
FIR TREE CAPITAL MANAGEMENT LP	13F	Company	0.41%	4,693,843	$265,014,000	—	30 Sep 2015	13F
EATON VANCE MANAGEMENT	13F	Company	0.41%	4,680,834	$264,280,000	—	30 Sep 2015	13F
First Eagle Investment Management, LLC	13F	Company	0.39%	4,467,011	$252,207,000	—	30 Sep 2015	13F
D. E. Shaw & Co., Inc.	13F	Company	0.39%	4,430,046	$250,121,000	—	30 Sep 2015	13F
Clal Insurance Enterprises Holdings Ltd	13F	Company	0.38%	4,361,197	$246,233,000	—	30 Sep 2015	13F
GLENVIEW CAPITAL MANAGEMENT, LLC	13F	Company	0.36%	4,188,779	$236,498,000	—	30 Sep 2015	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.36%	4,188,528	$236,484,000	—	30 Sep 2015	13F
BlackRock Group LTD	13F	Company	0.35%	4,038,981	$228,041,000	—	30 Sep 2015	13F
JPMORGAN CHASE & CO	13F	Company	0.34%	3,949,276	$222,975,000	—	30 Sep 2015	13F
RUSSELL FRANK CO/	13F	Company	0.33%	3,783,527	$213,588,000	—	30 Sep 2015	13F
Capital Research Global Investors	13F	Company	0.32%	3,712,000	$209,580,000	—	30 Sep 2015	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.32%	3,684,204	$208,010,000	—	30 Sep 2015	13F
Clearbridge Investments, LLC	13F	Company	0.32%	3,633,803	$205,165,000	—	30 Sep 2015	13F
Neuberger Berman Group LLC	13F	Company	0.32%	3,623,566	$204,587,000	—	30 Sep 2015	13F
BlackRock Investment Management, LLC	13F	Company	0.31%	3,594,042	$202,920,000	—	30 Sep 2015	13F
Senator Investment Group LP	13F	Company	0.3%	3,500,000	$197,610,000	—	30 Sep 2015	13F
MACQUARIE GROUP LTD	13F	Company	0.3%	3,488,850	$196,981,000	—	30 Sep 2015	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	0.28%	3,257,771	$183,934,000	—	30 Sep 2015	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.28%	3,195,337	$180,409,000	—	30 Sep 2015	13F
BROWN ADVISORY INC	13F	Company	0.27%	3,095,871	$174,794,000	—	30 Sep 2015	13F
OppenheimerFunds, Inc.	13F	Company	0.26%	2,930,641	$165,464,000	—	30 Sep 2015	13F
Epoch Investment Partners, Inc.	13F	Company	0.25%	2,899,740	$163,719,000	—	30 Sep 2015	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.25%	2,878,763	$162,535,000	—	30 Sep 2015	13F
NORTH TIDE CAPITAL, LLC	13F	Company	0.24%	2,700,000	$152,442,000	—	30 Sep 2015	13F
SAMLYN CAPITAL, LLC	13F	Company	0.22%	2,531,000	$142,900,000	—	30 Sep 2015	13F
NWQ INVESTMENT MANAGEMENT COMPANY, LLC	13F	Company	0.21%	2,408,826	$136,002,000	—	30 Sep 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.21%	2,395,331	$135,237,000	—	30 Sep 2015	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.2%	2,257,491	$127,424,000	—	30 Sep 2015	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.2%	2,254,216	$127,266,000	—	30 Sep 2015	13F

Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q4 2015

As of 31 Dec 2015, TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by 871 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 609,619,633 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, Viking Global Investors LP, PAULSON & CO. INC., Invesco Ltd., WADDELL & REED FINANCIAL INC, LAZARD ASSET MANAGEMENT LLC, Capital Research Global Investors, NORGES BANK, and BARROW HANLEY MEWHINNEY & STRAUSS LLC. This page lists 872 institutional shareholders reporting positions in this security for the Q4 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2015 vs Q3 2015 Across Filers

Q3 2015 holders

812

Q4 2015 holders

871

Holder diff

Investor	Q3 2015 Shares	Q4 2015 Shares	Share Diff	Share Chg %	Q3 2015 Value $	Q4 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.